Showing results (2291-2300 of 2,411) with videos related to
Sort By:
Pageof 242
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)A Kurreck, M Geissler, U M Martens, et al.The Lancet. Respiratory Medicine|October 17, 2017
Palliative care in interstitial lung disease: living wellMichael Kreuter, Elisabeth Bendstrup, Anne-Marie Russell, et al.British Journal of Cancer|November 22, 2012
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104S Boeck, A Jung, R P Laubender, et al.Science Translational Medicine|March 22, 2023
The enhancer landscape predetermines the skeletal regeneration capacity of stromal cellsSarah Hochmann, Kristy Ou, Rodolphe Poupardin, et al.BMC Cancer|August 29, 2014
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104Steffen Ormanns, Jens T Siveke, Volker Heinemann, et al.Cancers|February 15, 2022
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb EfficacyAnnabel H S Alig, Volker Heinemann, Michael Geissler, et al.Frontiers in Immunology|November 30, 2019
Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional PropertiesAnastazja Andrzejewska, Rusan Catar, Janosch Schoon, et al.Child and Adolescent Psychiatry and Mental Health|December 16, 2024
Psychometric properties of the parent-rated assessment scale of positive and negative parenting behavior (FPNE) in a German sample of school-aged childrenVanessa Holas, Ann-Kathrin Thöne, Christina Dose, et al.The Lancet. Oncology|September 4, 2025
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of CancerIan F Tannock, Madeline Lee Pe, Christopher M Booth, et al.Blood Advances|January 4, 2018
Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor functionEliana Ribechini, James A Hutchinson, Sabine Hergovits, et al.Pageof 242